The treatment of tuberculosis.
D000636:Aminosalicylic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D002207:Capreomycin / Q000009:adverse effects / Q000627:therapeutic use; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D005000:Ethionamide / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D011515:Prothionamide / Q000009:adverse effects / Q000627:therapeutic use; D011718:Pyrazinamide / Q000009:adverse effects / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013307:Streptomycin / Q000008:administration & dosage / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy* / Q000628:therapy
D000636:Aminosalicylic Acids; D002207:Capreomycin; D011718:Pyrazinamide; D011515:Prothionamide; D004977:Ethambutol; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin